People
Electron Kebebew
Chief of the Division of General Surgery & Lab Director
Dr. Kebebew is an internationally recognized expert in Endocrine Oncology and Surgery. He has performed more than three thousand operations on the adrenal, parathyroid and thyroid glands, and for neuroendocrine tumors of the gastrointestinal tract and pancreas.
Dr. Kebebew has published over 400 articles, chapters and textbooks, and serves on the editorial board and as a reviewer for 54 biomedical journals. He has received awards from the American Cancer Society, American Association for Cancer Research, American Thyroid Association, American Association of Endocrine Surgeons, and International Association of Endocrine Surgeons.
Chandrayee Ghosh, PhD
As a postdoctoral scholar in Dr. Kebebew’s Laboratory, the prime focus of Dr. Chandrayee Ghosh's research is to develop novel identification methods as well as therapeutic strategies for rare endocrine cancers. Previously, she was appointed as a postdoctoral scholar in the University of Kansas Medical Center where she studied pancreatic cancer (PDAC) and key signaling pathways in PDAC progression using various genetic and epigenetic approaches. She received her PhD from University of Calcutta, India for her work on characterizing innate immune response in both chronic and acute inflammatory models of infectious disease.
Jiangnan Hu, PhD
Jiangnan Hu, PhD is a post-doc in the Department of Surgery, Division of General and Vascular Surgery. His publications include:
- Combination BRAFV600E inhibition with the multitargeting tyrosine kinase inhibitor axitinib shows additive anticancer activity in BRAFV600E-mutant anaplastic thyroid cancer
- Combination nitazoxanide and auranofin treatment has synergistic anticancer activity in anaplastic thyroid cancer and act by enhanced activation of multiple cell death pathways
- Generation and maintenance of anaplastic thyroid cancer spheroids from human cancer cells